RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,305 filers reported holding RAYTHEON CO in Q4 2017. The put-call ratio across all filers is 2.41 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $46,000 | -65.2% | 350 | -41.9% | 0.00% | -60.0% |
| Q4 2019 | $132,000 | +11.9% | 602 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $118,000 | +12.4% | 602 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $105,000 | -4.5% | 602 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $110,000 | +205.6% | 602 | +158.4% | 0.01% | +150.0% |
| Q4 2018 | $36,000 | -28.0% | 233 | -4.1% | 0.00% | 0.0% |
| Q3 2018 | $50,000 | +11.1% | 243 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $45,000 | -10.0% | 233 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $50,000 | +4.2% | 233 | -7.9% | 0.00% | 0.0% |
| Q4 2017 | $48,000 | +2.1% | 253 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $47,000 | +14.6% | 253 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $41,000 | +28.1% | 253 | +19.3% | 0.00% | 0.0% |
| Q1 2017 | $32,000 | +6.7% | 212 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $30,000 | +3.4% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $29,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | +11.5% | 212 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $26,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $26,000 | +13.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $23,000 | +15.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $20,000 | -13.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $23,000 | -99.9% | 212 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $22,932,000 | +6.4% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $21,543,000 | +10.2% | 212 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $19,557,000 | – | 212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |